Purchase
Description
Evolocumab biosimilaris a human monoclonal immunoglobulin G2 (IgG2) directed against human proprotein convertase subtilisin kexin 9 (PCSK9). Evolocumab biosimilarhas an approximate molecular weight (MW) of 144 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells.
Evolocumab biosimilar is supplied at a concentration of 140 mg/mL as a sterile, preservative-free, clear to opalescent, colorless to pale yellow solution, which contains 1.2 mg/mL acetate, 0.1 mg/mL polysorbate 80, 25 mg/mL proline, and Water for Injection.
Statement: this product is used for R&D only, not for clinical usage.
Properties
|
Name
|
Evolocumab biosimilar
|
|
CAS
NO.
|
1256937-27-5
|
|
Type
|
Whole
antibody
|
|
Source
|
Human
|
|
Target
|
PCSK9
|
|
Clone
|
Monoclone
|
|
Molecular
Weight
|
144 kDa
|
|
Formula
|
C6242H9648N1668O1996S56
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Storage
|
-70±15℃ for long-term
storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508154126192619.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Evolocumab
|
